CHEMBL256470
| SMILES | Cc1csc2c(N[C@@H](C)CN3CCN(S(=O)(=O)c4ccc(Cl)c(Cl)c4)CC3)ncnc12 |
| InChIKey | BPRNMVDTWIHULJ-AWEZNQCLSA-N |
Chemical properties
| Hydrogen bond acceptors | 7 |
| Hydrogen bond donors | 1 |
| Rotatable bonds | 6 |
| Molecular weight (Da) | 499.1 |
Drug properties
| Molecular type | Small molecule |
| Physiological/Surrogate | Surrogate |
| Approved drug | No |
Database connections
Bioactivities
| Receptor | Activity | Source | |||||||
|---|---|---|---|---|---|---|---|---|---|
| GTP | Uniprot | Species | Family | Class | Type | Min | Avg | Max | Database |
| β3 | ADRB3 | Human | Adrenoceptors | A | pKi | 5.05 | 5.05 | 5.05 | ChEMBL |
| D3 | DRD3 | Human | Dopamine | A | pKi | 6.24 | 6.24 | 6.24 | ChEMBL |
| κ | OPRK | Human | Opioid | A | pKi | 6.31 | 6.31 | 6.31 | ChEMBL |
| Receptor | Activity | Source | |||||||
|---|---|---|---|---|---|---|---|---|---|
| GTP | Uniprot | Species | Family | Class | Type | Min | Avg | Max | Database |
| LPA2 | LPAR2 | Mouse | Lysophospholipid (LPA) | A | pIC50 | 6.49 | 6.51 | 6.53 | ChEMBL |
| LPA4 | LPAR4 | Human | Lysophospholipid (LPA) | A | pIC50 | 5.2 | 5.2 | 5.2 | ChEMBL |
| LPA2 | LPAR2 | Human | Lysophospholipid (LPA) | A | pIC50 | 6.17 | 6.7 | 7.77 | ChEMBL |
| LPA3 | LPAR3 | Human | Lysophospholipid (LPA) | A | pIC50 | 4.41 | 4.41 | 4.41 | ChEMBL |
| LPA1 | LPAR1 | Human | Lysophospholipid (LPA) | A | pIC50 | 5.01 | 5.01 | 5.01 | ChEMBL |
| GPR35 | GPR35 | Human | Orphan | A | pIC50 | 6.22 | 6.22 | 6.22 | ChEMBL |